Globus Spirits (GLOBUSSPR)

FairStock Score: 35/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 19.10% with latest quarter revenue of ₹716 Cr shows expanding business momentum.
• Piotroski F-Score of 7/9 indicates sound short-term financial health across profitability, leverage, and efficiency.
• Moderate Debt/Equity of 0.45 provides balance-sheet stability.
• Promoter holding of 50.75% aligns majority shareholder interest with minority investors.
• Latest quarter net profit of ₹31 Cr suggests improving operating leverage and margin recovery.

Concerns

• P/E of 32.57 and P/B of 3.01 imply expensive valuation with little margin of safety.
• ROE of 7.55% and ROCE of 5.80% are weak; ROCE is likely below the cost of capital.
• 1,000% profit growth is a low-base effect; PEG of 0.06 is misleading and unsustainable.
• Dividend yield of only 0.31% means shareholders get negligible cash returns while relying fully on future growth.

AI Analysis

At ₹1,013, Globus Spirits is not the kind of business I would normally stop for. The selling price gives me a trailing P/E of 32.57 and a P/B of 3.01 against book value of ₹336.20. That means I am paying over three times book for a company that earns only 7.55% on equity and 5.80% on capital employed. The ROCE is below what a prudent investor should demand from any industrial asset, so the business as it stands is not compounding wealth at an attractive rate. The latest quarter does show promise: sales of ₹716 Cr and net profit of ₹31 Cr prove that operating leverage can work. And the top line has grown 19.10%. But the 1,000% profit growth is a classic low-base distortion; the trailing earnings are roughly ₹79.6 Cr, which makes the PEG of 0.06 meaningless. A 32.57 P/E on a business with 7.55% ROE is no bargain. Promoter holding of 50.75% is good, but it does not create a moat in a competitive, regulation-heavy liquor industry. The balance sheet is acceptable with D/E at 0.45, and the Piotroski score of 7/9 suggests near-term financial health. Still, the dividend yield of 0.31% means the shareholder is dependent entirely on future growth to justify today's price. I would need many quarters of ₹30 Cr-plus profits before I could treat this as a proven compounder. Until then, this is a watchlist candidate rather than a conviction buy. If the business keeps growing sales and converts to higher margins, the price may eventually look fair; at ₹1,013, the margin of safety is missing. As Graham said, price is what you pay, value is what you get; here, I am not sure value has arrived.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer